IJSTX | VSCIX | IJSTX / VSCIX | |
Total Expense Ratio | 1.28 | 0.04 | 3,200% |
Annual Report Gross Expense Ratio | 1.28 | 0.04 | 3,200% |
Fund Existence | 23 years | 28 years | - |
Gain YTD | -8.632 | -7.311 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 311M | 153B | 0% |
Annual Yield % from dividends | 0.07 | 1.53 | 5% |
Returns for 1 year | -3.77 | 0.02 | -19,751% |
Returns for 3 years | -25.41 | 5.01 | -507% |
Returns for 5 years | 45.10 | 112.54 | 40% |
Returns for 10 years | -32.07 | 89.33 | -36% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNNX | 67.71 | 0.80 | +1.20% |
Janus Henderson Global Life Sciences N | |||
HLEMX | 36.70 | N/A | N/A |
Harding Loevner Emerging Markets Advisor | |||
ASQIX | 14.91 | N/A | N/A |
American Century Small Company Inv | |||
RYAKX | 48.17 | N/A | N/A |
Rydex Russell 2000 1.5x Strategy A | |||
THOGX | 39.13 | -0.01 | -0.03% |
Thornburg Global Opportunities R6 |